Analytical and clinical validation of a digital sequencing panel for quantitative, highly accurate evaluation of cell-free circulating tumor DNA

Autor: Collisson, Eric, Lanman, RB, Mortimer, SA, Zill, OA, Sebisanovic, D, Lopez, R, Blau, S, Collisson, EA, Divers, SG, Hoon, DSB, Scott, E

Publikováno v: Collisson, Eric; Lanman, RB; Mortimer, SA; Zill, OA; Sebisanovic, D; Lopez, R; et al.(2015). Analytical and clinical validation of a digital sequencing panel for quantitative, highly accurate evaluation of cell-free circulating tumor DNA. UC San Francisco: Retrieved from: http://www.escholarship.org/uc/item/2967n1gx

© 2015 Lanman et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are cr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______325::52553b1ae3fbbe590e51b4efec292f76
http://www.escholarship.org/uc/item/2967n1gx

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Spectrum of driver mutations and clinical impact of circulating tumor DNA analysis in non-small cell lung cancer: Analysis of over 8000 cases.

Autor: Mack PC; Division of Hematology-Oncology, Department of Internal Medicine, University of California Davis Comprehensive Cancer Center, Sacramento, California.; College of Medicine, California Northstate University, Elk Grove, California., Banks KC; Guardant Health, Inc, Redwood City, California., Espenschied CR; Guardant Health, Inc, Redwood City, California., Burich RA; Division of Hematology-Oncology, Department of Internal Medicine, University of California Davis Comprehensive Cancer Center, Sacramento, California., Zill OA; Guardant Health, Inc, Redwood City, California., Lee CE; Guardant Health, Inc, Redwood City, California., Riess JW; Division of Hematology-Oncology, Department of Internal Medicine, University of California Davis Comprehensive Cancer Center, Sacramento, California., Mortimer SA; Guardant Health, Inc, Redwood City, California., Talasaz A; Guardant Health, Inc, Redwood City, California., Lanman RB; Guardant Health, Inc, Redwood City, California., Gandara DR; Division of Hematology-Oncology, Department of Internal Medicine, University of California Davis Comprehensive Cancer Center, Sacramento, California.

Publikováno v: Cancer [Cancer] 2020 Jul 15; Vol. 126 (14), pp. 3219-3228. Date of Electronic Publication: 2020 May 04.

Analytical and Clinical Validation of a Digital Sequencing Panel for Quantitative, Highly Accurate Evaluation of Cell-Free Circulating Tumor DNA.

Autor: Lanman RB; Department of Medical Affairs, Guardant Health, Inc., Redwood City, California, United States of America., Mortimer SA; Department of Research and Bioinformatics, Guardant Health, Inc., Redwood City, California, United States of America., Zill OA; Department of Research and Bioinformatics, Guardant Health, Inc., Redwood City, California, United States of America., Sebisanovic D; Department of Research and Bioinformatics, Guardant Health, Inc., Redwood City, California, United States of America., Lopez R; Department of Research and Bioinformatics, Guardant Health, Inc., Redwood City, California, United States of America., Blau S; Rainier Hematology Oncology, Northwest Medical Specialties, Puyallup, Washington, United States of America., Collisson EA; Department of Medicine, University of California San Francisco School of Medicine, San Francisco, California, United States of America., Divers SG; Genesis Cancer Center, Hot Springs, Arkansas, United States of America., Hoon DS; Department of Molecular Oncology, John Wayne Cancer Institute at Saint John's Health Center, Santa Monica, California, United States of America., Kopetz ES; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America., Lee J; Department of Medicine, Division of Hematology-Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Nikolinakos PG; Department of Hematology and Medical Oncology, University Cancer and Blood Center, Athens, Georgia, United States of America., Baca AM; Department of Medical Affairs, Guardant Health, Inc., Redwood City, California, United States of America., Kermani BG; Department of Research and Bioinformatics, Guardant Health, Inc., Redwood City, California, United States of America., Eltoukhy H; Administration, Guardant Health, Inc., Redwood City, California, United States of America., Talasaz A; Department of Research and Bioinformatics, Guardant Health, Inc., Redwood City, California, United States of America; Administration, Guardant Health, Inc., Redwood City, California, United States of America.

Publikováno v: PloS one [PLoS One] 2015 Oct 16; Vol. 10 (10), pp. e0140712. Date of Electronic Publication: 2015 Oct 16 (Print Publication: 2015).